News
Alzheimer’s disease is a serious condition that mostly affects older people. It causes memory loss, confusion, and changes in how a person thinks and behaves. It’s the most common cause of dementia, a ...
Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market ...
"The scale at which we analyzed the amyloid peptides was unprecedented," said Ben Lehner of the Wellcome Sanger Institute.
In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, ...
By analyzing thousands of Aβ42 peptides, the scientists gained a better understanding of how mutations in Aβ affect protein ...
Inspired by advances in cancer therapy, a team at the Buck Institute has engineered immune cells equipped with specialized ...
Taking inspiration from the CAR T-cell technology used to provide personalized cancer treatments, researchers have conducted ...
A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...
A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results